Company Search:
Advanced Search
Sponsored Links
Endocyte, Inc. Company Snapshot
Endocyte, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Endocyte with three other companies in this sector in the United States: Americann Inc (2017 sales of $40,000.00 ), Sangui Biotech International, Incorporated ($67,653.00 ), and RegeneRx Biopharmaceuticals, Inc. ($56,652.00 ).

Sales Analysis. During the year ended December of 2017, sales at Endocyte were $70,000.00 . This is a very small increase of 0.0% versus 2016, when the company's sales were $70,000.00 .
  Stock Performance Chart for Endocyte, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (12/20/2018): 23.99
(Figures in U.S. Dollars)
1 Week 0.6%   13 Weeks 1.7%  
4 Weeks 36.9%   52 Weeks 464.5%  
Endocyte, Inc. Key Data:
  Ticker: ECYT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 70,000
(Year Ending Jan 2018).
Employees: 44
  Currency: U.S. Dollars Market Cap: N/A
  Fiscal Yr Ends: December Shares Outstanding: N/A
  Share Type: Common Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.